The test is the first in a proposed line of assays that will run on the GeneXpress platform with run times of around 30 minutes.
The deal suggests the company is making steady progress toward its goal of signing coverage deals with all major private payors by year end.
Results from a study using the database showed that patients with high expression of a certain gene signature had better outcomes with radiation therapy than without it.
Researcher Gordon Mills said assays based on his lab's Cancer Proteome Atlas project could be used to guide patient treatment within the next 18 months.
Researchers at the Hartwig Medical Foundation have launched a clinical trial that seeks to match tumor biomarkers with experimental and off-label drugs.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.